Rhone Ma Holdings Berhad

RM 0.69As of Sun 8 Nov 2026, 12:00 UTC
KLSE:RHONEMAHealthcare
Country Malaysia
PE (Fwd) •••
TSR 10Y CAGR 0.56%
Div yield 3.65%
ROE 7.79%
Pharmaceutical Preparations
Beta (5Y) 0.12
PE TTM 12.38
TSR TTM 1.52%
Mkt cap RM 151.6M
ROIC 10.53%
SE Grade™
Value
Quality
Moat
Consensus
Reference
RM 0.87
26.94%
0.19%
Hold 9|11|8|2|6
4Q25
1Q26
2Q26
3Q26
Earnings per shareRM
0.01
0.01
0.01
0.01
(2.99%)
5.31%
6.47%
1.86%
RevenueRM M
18.63
18.74
18.55
19.33
9.88%
13.41%
8.06%
7.23%
Peers (US$37.37M)
Cap (US$)
PE
43.06M
18.18x
30.25M
14.38x
37.50M
74.64x
Capital
TTM
5Y
10Y
Leveragex
0.084
0.645
0.517
EBIT/Intx
0.289
0.150
0.126
Own earn%
43.83
(97.56)
(128.22)
Sh yield%
36.25
35.86
35.56
Owners
Insiders/Inst%
8.20
60.74
Short interest%
1.81
SBC / revenue%
5.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
22–30
$1 testx
—
Incr. ROIC%
2